Definium Therapeutics, formerly MindMed, is a clinical-stage biopharmaceutical company developing psychedelic medicines — most notably an LSD-based therapy — for generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its pipeline targets root causes of conditions where existing treatments routinely fall short, with patient populations measured in tens of millions in the US alone. The company trades on Nasdaq under DFTX and rebranded from MindMed in January 2026 after raising a $259M public offering. The team is remote-first with fully covered medical, dental, and vision, paid parental leave, and equity for all employees — unusual for a small-cap biotech.
Senior Product Manager, HCP Marketing
This is a remote senior product manager role focused on biopharmaceutical HCP marketing. The PM will own the development and execution of HCP promotional strategies, including brand planning, launch readiness, and promotional initiatives. This role requires strong pharmaceutical marketing expertise, managing agency partners, and involves a starting base pay range of $170k–$197k per year.
Director, Product Communications
This is a Director-level product communications role, remote, focused on the biopharmaceutical domain. The Director will own strategic communications for the company's late-stage pipeline, including Phase 3 data readouts and potential regulatory filings. The role requires deep pharmaceutical experience, managing integrated PESO campaigns, and involves a starting base pay range of $192k–$226k per year.
Product Manager Jobs at Definium Therapeutics
Browse open product manager positions at Definium Therapeutics. Remote PM Jobs pulls listings directly from Definium Therapeutics’s applicant tracking system so you always apply at the source. This page updates daily.